Clinics
Age and sex: 4 years old female patient. Previous History : no preleukemia; no previous malignant disease; no inborn condition of note. Organomegaly : hepatomegaly; splenomegaly; enlarged lymph nodes; no central nervous system involvement.
Blood
WBC: 148 x 10 9 /l; Hb: 9.8 g/dl; platelets: 13x 10 9 /l; blasts: peripheral 60%. Bone marrow: 100% Partial karyotypes of metaphases from diagnostic sample overnight colcemid culture. Laffin JJS, et al. Atlas Genet Cytogenet Oncol Haematol. 2008; 12(5) 
Cytopathology classification

Translocation t(7;9)(q34;q32) found in pediatric T-cell acute lymphoblastic leucemia
418
Comments
The patient presented in this case report has features consistent with other reported cases of T cell acute lymphoblastic leukemia (T-ALL) with t(7;9)(q34;q32) involving the TCRbeta locus on 7q34 and the TAL2 gene on 9q34. In particular, review of the literature revealed a case in a 3 year old male with similar clinical and hematological findings and the same additional cytogenetic anomaly, del(6)(q21). Approximately 60% of clinically normal individuals have t(7;9)(q34;q32) created by V(D)J recombination which uses a fortuitous recombination site (RSS) located 3'of the TAL2 oncogene. In T-ALL affected individuals a rare second rearrangement occurs between the junction point of the original t(7;9) and Jbeta2. This brings the TAL2 gene under the control of TCRbeta enhancer, and leads to its' inappropriate expression.
